Radiation-Induced Recurrent Vesicovaginal Fistula-Treatment with Adjuvant Platelet-Rich Plasma Injection and Martius Flap Placement-Case Report and Review of Literature

Vesicovaginal Fistula and Hydronephrosis Post-radiation for Cervical Cancer: Challenges and Strategies in Management

This report meticulously examines a complex case involving a vesicovaginal fistula (VVF) and hydronephrosis following radiation treatment for stage IV cervical cancer. It highlights the challenges and nuanced treatment strategies essential for addressing such complications, particularly given the patient's comprehensive medical background, including her cancer treatment and subsequent radiation therapy. Through an in-depth case study, the report details the diagnostic process, emphasizing the role of advanced imaging techniques and clinical evaluations in detecting a VVF along with hydronephrosis - illustrating the delayed adverse effects of radiation therapy. The treatment strategy employed a laparoscopic surgical technique, coupled with a carefully devised postoperative care plan focusing on hydration and anti-inflammatory measures to counteract radiation cystitis and prevent further issues. This narrative not only showcases the complex challenges of managing complications such as VVF and hydronephrosis post-radiation but also underlines the critical need for personalized, interdisciplinary care approaches. These approaches strive to effectively treat cancer while prioritizing the patient's quality of life. Furthermore, the report adds valuable insights to the ongoing dialogue on improving care for individuals facing the enduring impacts of cancer treatments. It argues for a comprehensive approach that includes preventive measures, prompt diagnostic procedures, and customized care strategies to improve the health and quality of life for cancer survivors.

Platelet rich plasma for the management of urogynecological disorders: the current evidence

PURPOSE OF REVIEW

Our objective is to review the currently available literature on the use of platelet-rich plasma (PRP) in patients with pelvic floor disorders and to critically appraise the latest evidence on the safety and efficacy of the PRP application.

RECENT FINDINGS

The evidence on the use of PRP for the treatment of stress urinary incontinence (SUI) appears promising, although limited to case series, case reports and animal studies. PRP has also been proposed to enhance the surgical outcomes of pelvic organ prolapse (POP) by native tissue repair with promising success rates. The application of PRP in other PFDs including vaginal fistulas, genitourinary syndrome of menopause (GSM), mesh exposure and lichen sclerosus has been also associated with beneficial outcomes and a favorable safety profile.

SUMMARY

The currently available literature indicates that PRP could have a beneficial effect as a single or adjuvant treatment in patients with SUI, POP, GSM, vaginal fistula and genital lichen sclerosus with minimal adverse events. However, valid evidence is still lacking and further well-designed studies are warranted in the field to confirm the validity of the so far reported outcomes.